Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Retatrutide commercial formulation details have not been finalized, but it will likely be available in similar delivery formats upon approval
Personalized nutrition targets
However, the risk for thyroid cancer was significantly higher within the first year after GLP-1RA initiation and was amplified in the overall as-treated analysis that censored patients when therapy was discontinued or another medication was added. The research team indicates this could be a sign that GLP-1 users are being screened for thyroid cancer at a higher rate than other diabetes drugs, resulting in a spike in diagnoses in the first year of taking the drug
doi: 10.1371/journal.pone.0045047 323 ZhouMYuanWYangBPeiWMaJFengQ
